Nasal Dilators Can Carry "Transient Causes" Indications - FDA Final Rule
This article was originally published in The Tan Sheet
Indicated uses of external nasal dilators may include "transient causes" as well as structural abnormalities that result in breathing difficulty, FDA determines in a final rule on the classification of the devices slated for publication in the March 8 Federal Register.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC